Predictive testing for hereditary breast and ovarian cancer: a psychological framework for pre-test counselling

被引:0
|
作者
Marleen Decruyenaere
Gerry Evers-Kiebooms
Lieve Denayer
Myriam Welkenhuysen
Erna Claes
Eric Legius
Koen Demyttenaere
机构
[1] Centre for Human Genetics,Department of Psychiatry
[2] University of Leuven,undefined
[3] University of Leuven,undefined
来源
关键词
Hereditary breast and ovarian cancer; BRCA1; BRCA2; predictive testing; genetic counselling; psychological aspects;
D O I
暂无
中图分类号
学科分类号
摘要
Since the identification of two breast–ovarian cancer susceptibility genes (BRCA1/2), predictive testing for hereditary breast/ovarian cancer (HBOC) has been available. Given the complexity and uncertainties of HBOC and the potential impact of predictive testing on psychological well-being, we offer the test applicants a combination of information-oriented and psychological counselling. In this paper, we describe the multidisciplinary approach for predictive testing for HBOC as a clinical service in Leuven, hereby focusing on psychological and decision counselling practice. Attention is paid to the theoretical framework used for pre-test psychological counselling in Leuven. We discuss three important interacting dimensions of psychological counselling: individual emotional support, decision counselling and support of the family communication process. Decision counselling consists of an evaluation of the cognitive and the emotional processing of the information given and strategies and resources for coping. This serves as a starting point to facilitate free informed decision making. Scenario development is used as a decision aid.
引用
收藏
页码:130 / 136
页数:6
相关论文
共 50 条
  • [1] Predictive testing for hereditary breast and ovarian cancer: a psychological framework for pre-test counselling
    Decruyenaere, M
    Evers-Kiebooms, G
    Denayer, L
    Welkenhuysen, M
    Claes, E
    Legius, E
    Demyttenaere, K
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2000, 8 (02) : 130 - 136
  • [2] Presymptomatic testing for hereditary breast/ovarian cancer (HBOC): Is there psychological distress in the pre-test period?
    Lodder, LN
    Frets, PG
    Trijsburg, RW
    de Wit, ACD
    Tibben, A
    Meijers-Heijboer, EJ
    Klijn, JGM
    Seynaeve, C
    Niermeijer, MF
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S123 - S123
  • [3] Diagnostic genetic testing for hereditary breast and ovarian cancer in cancer patients: Women's looking back on the pre-test period and a psychological evaluation
    Claes, E
    Evers-Kiebooms, G
    Boogaerts, A
    Decruyenaere, M
    Denayer, L
    Legius, E
    GENETIC TESTING, 2004, 8 (01): : 13 - 21
  • [4] Mainstreaming genomic testing: pre-test counselling and informed consent
    Cormack, Michaela
    Irving, Kathryn B.
    Cunningham, Fiona
    Fennell, Andrew P.
    MEDICAL JOURNAL OF AUSTRALIA, 2024, 220 (08) : 403 - 406
  • [5] Risk Perception and Psychological Distress in Genetic Counselling for Hereditary Breast and/or Ovarian Cancer
    Cicero, G.
    De Luca, R.
    Dorangricchia, P.
    Lo Coco, G.
    Guarnaccia, C.
    Fanale, D.
    Calo, V.
    Russo, A.
    JOURNAL OF GENETIC COUNSELING, 2017, 26 (05) : 999 - 1007
  • [6] Predictive testing for hereditary breast and ovarian cancer (HBOC): psychological impact and health related behaviour in the year following the communication of the predictive test result
    Claes, E
    Evers-Kiebooms, G
    Decruyenaere, M
    Denayer, L
    Boogaerts, A
    Legius, E
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S78 - S78
  • [7] Genetic counselling and testing for hereditary breast and ovarian cancer: The gent(le) approach
    De Vos, M
    Poppe, B
    Delvaux, I
    Mortier, G
    Claes, K
    Messiaen, L
    De Paepe, A
    DISEASE MARKERS, 1999, 15 (1-3) : 191 - 195
  • [8] Predictive testing for hereditary breast and ovarian cancer (HBOC): Psychological impact and health related behaviour in the year following the communication of the predictive test result.
    Claes, E
    Evers-Kiebooms, G
    Decruyenaere, M
    Denayer, L
    Boogaerts, A
    Legius, E
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 318 - 319
  • [9] Hereditary breast and ovarian cancer: Epidemiology, genetics, screening and predictive testing
    Foulkes, WD
    Narod, SA
    CLINICAL AND INVESTIGATIVE MEDICINE, 1995, 18 (06): : 473 - 483
  • [10] Ethics of predictive DNA-testing for hereditary breast and ovarian cancer
    de Wert, G
    PATIENT EDUCATION AND COUNSELING, 1998, 35 (01) : 43 - 52